RELAPSED/REFRACTORY MULTIPLE MYELOMA(MM)
Clinical trials for RELAPSED/REFRACTORY MULTIPLE MYELOMA(MM) explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY MULTIPLE MYELOMA(MM) trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY MULTIPLE MYELOMA(MM), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cell therapy takes on Hard-to-Treat multiple myeloma
Disease control Recruiting nowThis study is testing an experimental cell therapy called LCAR-F33S in 35 adults with multiple myeloma that has returned or stopped responding to standard treatments. The main goals are to check safety, find the best dose, and see how well the therapy works against the cancer. Pa…
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA(MM)
Phase: NA • Sponsor: Nanjing Legend Biotech Co. • Aim: Disease control
Last updated May 26, 2026 12:11 UTC
-
New immune cell attack shows promise against stubborn blood cancer
Disease control Recruiting nowThis early-stage study tests a new treatment called HBI0101 CART for people with multiple myeloma, a type of blood cancer, that has returned or not responded to standard therapies. The treatment uses a patient's own immune cells, modified in a lab to better recognize and kill can…
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA(MM)
Phase: PHASE1 • Sponsor: Hadassah Medical Organization • Aim: Disease control
Last updated May 22, 2026 14:05 UTC
-
New CAR-T therapy targets Hard-to-Treat multiple myeloma in early trial
Disease control Recruiting nowThis early-stage study tests a new treatment for adults with multiple myeloma that has returned or stopped responding to standard therapies. The treatment uses specially engineered immune cells from donated umbilical cord blood to attack cancer cells. The main goals are to check …
Matched conditions: RELAPSED/REFRACTORY MULTIPLE MYELOMA(MM)
Phase: PHASE1 • Sponsor: Xi'an No.3 Hospital • Aim: Disease control
Last updated May 18, 2026 12:02 UTC